Insulet Corp. Stock
Insulet Corp. Stock
Insulet Corp. gained 1.560% today.
The stock is one of the favorites of our community with 60 Buy predictions and 1 Sell predictions.
With a target price of 305 € there is potential for a 104.22% increase which would mean more than doubling the current price of 149.35 € for Insulet Corp..
So far the community has only identified positive things for Insulet Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Insulet Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | 1.560% | 2.367% | 5.906% | -41.693% | -39.783% | -42.243% | -36.149% |
| Haemonetics Corp. | 2.840% | 5.797% | 7.353% | - | 6.569% | - | - |
| CONMED Corp. | -0.520% | 3.825% | 21.795% | -13.636% | 8.571% | -64.486% | -66.957% |
| Penumbra Inc | -0.570% | 0.647% | 0.647% | 41.599% | 5.030% | 0.647% | 26.492% |
Comments
Insulet (PODD) was given a new $210.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Royal Bank Of Canada from $280.00 to $245.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (PODD) had its price target lowered by Stifel Nicolaus from $250.00 to $225.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat